HDMA Recognizes ABPG Pfizer With Inaugural Distribution Management Award
The
Pfizer’s Toviaz, a treatment for overactive bladders, was introduced to the market in 2008 using a child-resistant starter pack for physician samples. In partnership with ABPG company Anderson Packaging, the companies worked together to improve upon this design by transitioning to a more comprehensive package design, using ABPG’s IntuiDose™ child-resistant compliance-prompting format. This enhanced design helped Pfizer to deliver the medication more effectively and cost-efficiently. The improvements resulted in savings in the Toviaz physician sample program and a more patient-friendly product. The new packaging helped to lower processing and operation costs and led to more efficient transportation and distribution.
The Distribution Management Award is the successor to HDMA’s iBusiness Solution and Innovation for Success Awards. HDMA presents the award to a member company or companies that demonstrate the value of distribution by developing creative, results-oriented programs and processes in areas ranging from technology and operations to trade and promotional planning that benefit the healthcare supply chain, customers and consumers, and engage in successful trading partner relationships.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025